PON1 and hepatocellular carcinoma: A decrease in PON-1 protein in patients with hepatocellular carcinoma was associated with tumor recurrence, invasiveness, metastasis, as well as with the alterations in cell cycle, DNA replication, gap junctions, and p53 downstream pathways [188].